Free shipping— Canada $250+ CAD
PUFFINPEPTIDES
Voting candidateGHRP-2 research compound previewCatalogue preview · final packaging and presentation may vary if stocked

Five choices across your ballotUse votes only for compounds you would consider ordering

One vote per compoundEach candidate can be selected once on this browser

Flexible interest signalRemove or reassign a vote whenever you like

Help choose what Puffin stocks next
Performance Research

GHRP-2

GHRP-2, also known as pralmorelin, is a synthetic ghrelin-receptor agonist that stimulates pituitary growth-hormone release. It is studied as a GHSR-pathway reference and is not a GHRH analogue.

Voting round open One active vote per compound
Your ballot0 of 5 votes used

Loading your saved choices…

Interest onlyA vote is not an order, preorder, reservation, payment, or guarantee that this compound will be stocked.

GHRP-2 is currently being evaluated through customer voting and is not available to order. Final product specifications and batch documentation will be published only if it joins the catalogue.

Catalogue statusVoting candidate
CategoryPerformance Research
Research focusGhrelin-receptor activity
Ballot allowanceOne vote
Research guide

Understanding Ghrp-2

Explore the science, research focus, and key information behind this compound.

What is Ghrp-2?

GHRP-2 is a direct research reference for ghrelin-receptor-driven release pathways.

What Researchers Study

Researchers examine Ghrelin-receptor activity, Pituitary-response models, and Growth-hormone release signalling.

How Ghrp-2 Works

GHRP-2 activates the growth-hormone secretagogue receptor, the same receptor family used by ghrelin. That signal can promote GH release and may also affect appetite, ACTH, cortisol, and prolactin depending on exposure and model.

Research at a Glance

GH-release activity is established in endocrine studies. Controlled human studies have shown acute GH responses to GHRP-2. Those studies support a secretagogue mechanism, not long-term claims about muscle, fat, recovery, or ageing. GH may not be the only hormonal response. GHRP-2 can influence ACTH/cortisol and prolactin in some settings. Measuring only GH can hide an endocrine effect relevant to the experiment. Regional diagnostic use is not a general approval. Pralmorelin’s diagnostic role in Japan concerns a defined product and protocol. It does not establish anti-aging, performance, or clinical use for a catalogue vial.

Read the full Ghrp-2 evidence guideStudy design, primary sources, limitations, and unanswered questions.Open guide
Research-use statement

If this candidate is added to the catalogue, it would be offered for controlled laboratory research only. It is not for human consumption and is not represented as a medicine, treatment, supplement, or substitute for an approved product.